SCHEMBL732949

SCHEMBL732949

O=C(O)c1cc(C(=O)O)cc(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.57
FYN P06241 1/20 0.57
CYP1A2 P05177 1/20 0.50
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
KIF11 P52732 1/20 0.38
WDR5 P61964 1/20 0.38
TPMT P51580 3/20 0.37
CA3 P07451 2/20 0.37
CA6 P23280 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
EPAS1 Q99814 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18513400 0.96 LCK (0.52) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL29482054 0.89 CES2 (0.47) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL21609775 0.89 CES2 (0.47) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL11821992 0.87 LCK (0.44) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL11818964 0.87 LCK (0.44) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL23411175 0.87 LCK (0.44) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL29728960 0.87 LCK (0.44) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL21484540 0.87 TPMT (0.53) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL18503859 0.87 LCK (0.44) LCKFYNCYP1A2ALDH1A1MEN1
SCHEMBL27861923 0.87 NOTUM (0.45) LCKFYNCYP1A2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102958912-B Benzohydrol derivatives, a preparation process and pharmaceutical use thereof SHANGHAI HENGRUI PHARM CO LTD 2015-01-14 CN disclosed
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
CN-102958912-A Benzohydrol derivatives, a preparation process and pharmaceutical use thereof SHANGHAI HENGRUI PHARM CO LTD 2013-03-06 CN disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed
US-20040002572-A1 Material for an insulating film, coating varnish for an insulating film, and insulating film and semiconductor device using the same SUMITOMO BAKELITE COMPANY, LTD. (JP) 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 LCK 3891/4885FYN 3873/4885CYP1A2 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.